Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-078696
Filing Date
2025-08-14
Accepted
2025-08-14 16:36:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6376
  Complete submission text file 0001104659-25-078696.txt   8161
Mailing Address 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024
Business Address 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024 858-224-9600
KIORA PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

EIN.: 980443284 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88748 | Film No.: 251220150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 130 MAIN ST 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST 2ND FLOOR NEW CANAAN CT 06840 203-909-6430
Nantahala Capital Partners Limited Partnership (Filed by) CIK: 0001502725 (see all company filings)

EIN.: 201220305 | State of Incorp.: MA | Fiscal Year End: 1210
Type: SCHEDULE 13G